CRISPR Therapeutics AG (CRSP)
55.08
+2.70
(+5.15%)
USD |
NASDAQ |
May 06, 16:00
55.00
-0.08
(-0.15%)
After-Hours: 07:00
CRISPR Therapeutics Total Assets (Quarterly) : 2.726B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 26.48B |
| Beam Therapeutics, Inc. | 1.481B |
| Novartis AG | 118.53B |
| EvoNext Holdings SA | -- |
| Kuros Biosciences Ltd. | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 911.26M |
| Shareholders Equity (Quarterly) | 1.815B |
| Debt to Equity Ratio | 0.4341 |
| Current Ratio | 17.96 |
| Net Debt Paydown Yield | -2.46% |